ScoreComparison
Why is RaQualia Pharma, Inc. ?
1
With a growth in Operating Profit of 3076.44%, the company declared Outstanding results in Dec 25
- ROCE(HY) Highest at 4.38%
- RAW MATERIAL COST(Y) Fallen by -72.9% (YoY)
- NET SALES(Q) Highest at JPY 1,668.93 MM
2
With ROE of -8.11%, it has a risky valuation with a 3.00 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 96.78%, its profits have fallen by -114.4%
- At the current price, the company has a high dividend yield of 0
3
Market Beating Performance
- The stock has generated a return of 96.78% in the last 1 year, much higher than market (Japan Nikkei 225) returns of 36.73%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to RaQualia Pharma, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is RaQualia Pharma, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
RaQualia Pharma, Inc.
96.78%
0.36
85.08%
Japan Nikkei 225
38.94%
1.30
28.24%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.29%
EBIT Growth (5y)
2.10%
EBIT to Interest (avg)
62.14
Debt to EBITDA (avg)
22.67
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.33
Tax Ratio
65.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.16%
ROE (avg)
4.41%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.00
EV to EBIT
-102.34
EV to EBITDA
69.76
EV to Capital Employed
2.88
EV to Sales
4.92
PEG Ratio
NA
Dividend Yield
0.00%
ROCE (Latest)
-2.82%
ROE (Latest)
-8.11%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend35What is working for the Company
ROCE(HY)
Highest at 4.38%
RAW MATERIAL COST(Y)
Fallen by -72.9% (YoY
NET SALES(Q)
Highest at JPY 1,668.93 MM
OPERATING PROFIT(Q)
Highest at JPY 958.53 MM
OPERATING PROFIT MARGIN(Q)
Highest at 57.43 %
PRE-TAX PROFIT(Q)
Highest at JPY 869.13 MM
NET PROFIT(Q)
Highest at JPY 846.51 MM
EPS(Q)
Highest at JPY 35.65
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for RaQualia Pharma, Inc.
Net Sales
At JPY 1,668.93 MM has Grown at 126.1%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely positive
Net Sales (JPY MM)
Pre-Tax Profit
At JPY 869.13 MM has Grown at 940.21%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 846.51 MM has Grown at 760.73%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Net Sales
Highest at JPY 1,668.93 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 958.53 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 57.43 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 869.13 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 846.51 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 35.65
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Raw Material Cost
Fallen by -72.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at JPY 130.06 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
